+关注
金虎玩股
暂无个人介绍
IP属地：安徽
17
关注
0
粉丝
2
主题
0
勋章
主贴
热门
金虎玩股
2025-12-09
$黄金主连 2602(GCmain)$
金虎玩股
2025-11-24
👀
诺和诺德新疗法未展现出显著的阿尔茨海默病减缓效果
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4188105060992060","uuid":"4188105060992060","gmtCreate":1725001927104,"gmtModify":1762940270558,"name":"金虎玩股","pinyin":"jhwgjinhuwangu","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/a7034fabd6f05808492acc5802e834a6","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":17,"tweetSize":2,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.11.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"安徽","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":10,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":508773517164840,"gmtCreate":1765243625439,"gmtModify":1765244756014,"author":{"id":"4188105060992060","authorId":"4188105060992060","name":"金虎玩股","avatar":"https://static.tigerbbs.com/a7034fabd6f05808492acc5802e834a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4188105060992060","authorIdStr":"4188105060992060"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/FUT/GCmain\">$黄金主连 2602(GCmain)$ </a><v-v data-views=\"0\"></v-v> ","listText":"<a href=\"https://laohu8.com/FUT/GCmain\">$黄金主连 2602(GCmain)$ </a><v-v data-views=\"0\"></v-v> ","text":"$黄金主连 2602(GCmain)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/508773517164840","isVote":1,"tweetType":1,"viewCount":105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":503650320974512,"gmtCreate":1763984162287,"gmtModify":1763989350514,"author":{"id":"4188105060992060","authorId":"4188105060992060","name":"金虎玩股","avatar":"https://static.tigerbbs.com/a7034fabd6f05808492acc5802e834a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4188105060992060","authorIdStr":"4188105060992060"},"themes":[],"title":"","htmlText":"👀","listText":"👀","text":"👀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/503650320974512","repostId":"1152104432","repostType":2,"repost":{"id":"1152104432","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1763983663,"share":"https://www.laohu8.com/m/news/1152104432?lang=zh_CN&edition=full","pubTime":"2025-11-24 19:27","market":"us","language":"zh","title":"诺和诺德新疗法未展现出显著的阿尔茨海默病减缓效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1152104432","media":"老虎资讯综合","summary":"未显示出显著的阿尔茨海默病减缓效果。","content":"<html><head></head><body><p>周一， <a href=\"https://laohu8.com/S/NVO\">诺和诺德</a> 盘前直线下挫，截至发稿大跌超12%。诺和诺德公布的Evoke III期临床试验并未显示出在统计学上显著减缓阿尔茨海默病进展的作用。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2e8a2685789ca2300a6fa0e151e63ded\" title=\"\" tg-width=\"1170\" tg-height=\"429\"/></p><p><strong>EVOKE实验</strong></p><p>诺和诺德的EVOKE实验旨在测试和开发一种名为Amucantamab（也称为“点刺”或“刺突”）的新疗法，用于治疗阿尔兹海默病，特别是用于清除大脑中的淀粉样蛋白斑块。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>诺和诺德新疗法未展现出显著的阿尔茨海默病减缓效果</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n诺和诺德新疗法未展现出显著的阿尔茨海默病减缓效果\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2025-11-24 19:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>周一， <a href=\"https://laohu8.com/S/NVO\">诺和诺德</a> 盘前直线下挫，截至发稿大跌超12%。诺和诺德公布的Evoke III期临床试验并未显示出在统计学上显著减缓阿尔茨海默病进展的作用。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2e8a2685789ca2300a6fa0e151e63ded\" title=\"\" tg-width=\"1170\" tg-height=\"429\"/></p><p><strong>EVOKE实验</strong></p><p>诺和诺德的EVOKE实验旨在测试和开发一种名为Amucantamab（也称为“点刺”或“刺突”）的新疗法，用于治疗阿尔兹海默病，特别是用于清除大脑中的淀粉样蛋白斑块。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://community-static.tradeup.com/news/f08a53a8889b77ec7429556edaeae0b7","relate_stocks":{"NVO":"诺和诺德"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152104432","content_text":"周一， 诺和诺德 盘前直线下挫，截至发稿大跌超12%。诺和诺德公布的Evoke III期临床试验并未显示出在统计学上显著减缓阿尔茨海默病进展的作用。EVOKE实验诺和诺德的EVOKE实验旨在测试和开发一种名为Amucantamab（也称为“点刺”或“刺突”）的新疗法，用于治疗阿尔兹海默病，特别是用于清除大脑中的淀粉样蛋白斑块。","news_type":1,"symbols_score_info":{"NVO":2}},"isVote":1,"tweetType":1,"viewCount":218,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":508773517164840,"gmtCreate":1765243625439,"gmtModify":1765244756014,"author":{"id":"4188105060992060","authorId":"4188105060992060","name":"金虎玩股","avatar":"https://static.tigerbbs.com/a7034fabd6f05808492acc5802e834a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4188105060992060","idStr":"4188105060992060"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/FUT/GCmain\">$黄金主连 2602(GCmain)$ </a><v-v data-views=\"0\"></v-v> ","listText":"<a href=\"https://laohu8.com/FUT/GCmain\">$黄金主连 2602(GCmain)$ </a><v-v data-views=\"0\"></v-v> ","text":"$黄金主连 2602(GCmain)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/508773517164840","isVote":1,"tweetType":1,"viewCount":105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":503650320974512,"gmtCreate":1763984162287,"gmtModify":1763989350514,"author":{"id":"4188105060992060","authorId":"4188105060992060","name":"金虎玩股","avatar":"https://static.tigerbbs.com/a7034fabd6f05808492acc5802e834a6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4188105060992060","idStr":"4188105060992060"},"themes":[],"title":"","htmlText":"👀","listText":"👀","text":"👀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/503650320974512","repostId":"1152104432","repostType":2,"repost":{"id":"1152104432","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1763983663,"share":"https://www.laohu8.com/m/news/1152104432?lang=zh_CN&edition=full","pubTime":"2025-11-24 19:27","market":"us","language":"zh","title":"诺和诺德新疗法未展现出显著的阿尔茨海默病减缓效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1152104432","media":"老虎资讯综合","summary":"未显示出显著的阿尔茨海默病减缓效果。","content":"<html><head></head><body><p>周一， <a href=\"https://laohu8.com/S/NVO\">诺和诺德</a> 盘前直线下挫，截至发稿大跌超12%。诺和诺德公布的Evoke III期临床试验并未显示出在统计学上显著减缓阿尔茨海默病进展的作用。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2e8a2685789ca2300a6fa0e151e63ded\" title=\"\" tg-width=\"1170\" tg-height=\"429\"/></p><p><strong>EVOKE实验</strong></p><p>诺和诺德的EVOKE实验旨在测试和开发一种名为Amucantamab（也称为“点刺”或“刺突”）的新疗法，用于治疗阿尔兹海默病，特别是用于清除大脑中的淀粉样蛋白斑块。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>诺和诺德新疗法未展现出显著的阿尔茨海默病减缓效果</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n诺和诺德新疗法未展现出显著的阿尔茨海默病减缓效果\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2025-11-24 19:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>周一， <a href=\"https://laohu8.com/S/NVO\">诺和诺德</a> 盘前直线下挫，截至发稿大跌超12%。诺和诺德公布的Evoke III期临床试验并未显示出在统计学上显著减缓阿尔茨海默病进展的作用。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2e8a2685789ca2300a6fa0e151e63ded\" title=\"\" tg-width=\"1170\" tg-height=\"429\"/></p><p><strong>EVOKE实验</strong></p><p>诺和诺德的EVOKE实验旨在测试和开发一种名为Amucantamab（也称为“点刺”或“刺突”）的新疗法，用于治疗阿尔兹海默病，特别是用于清除大脑中的淀粉样蛋白斑块。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://community-static.tradeup.com/news/f08a53a8889b77ec7429556edaeae0b7","relate_stocks":{"NVO":"诺和诺德"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152104432","content_text":"周一， 诺和诺德 盘前直线下挫，截至发稿大跌超12%。诺和诺德公布的Evoke III期临床试验并未显示出在统计学上显著减缓阿尔茨海默病进展的作用。EVOKE实验诺和诺德的EVOKE实验旨在测试和开发一种名为Amucantamab（也称为“点刺”或“刺突”）的新疗法，用于治疗阿尔兹海默病，特别是用于清除大脑中的淀粉样蛋白斑块。","news_type":1,"symbols_score_info":{"NVO":2}},"isVote":1,"tweetType":1,"viewCount":218,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
